https://www.indianpharmapost.com/sun-pharmaceutical-industries-posts-consolidated-q2-fy26-pat-higher-at-rs-313709-cr-181792025-11-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-lifesciences-secures-fda-tentative-approval-for-olaparib-tablets-181802025-11-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-fda-final-approval-for-sumatriptan-injection-usp-181812025-11-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-announces-usfda-final-approval-for-dasatinib-tablets-181822025-11-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-bioresearch-center-receives-zero-observations-from-usfda-181832025-11-08T00:00:00+05:30always0.9